White House Conference on Women's Health Spotlights Funding, Investment and Innovation Challenges

The inaugural White House conference on women's health research marked a pivotal moment, spotlighting the critical need for increased funding and investment in an area historically overlooked. Attended by President Joe Biden, First Lady Jill Biden, and a multitude of stakeholders, the event discussed the innovative strides in women's health as well as the sector's vast yet largely untapped potential. Earlier, the Biden administration had committed $100 million through the Women's Health Research initiative to spur research, aiming to align public health interests with private sector investment. Despite a traditionally low venture capital presence in this sector, interest is growing, as illustrated by Sequoia Capital's investments in telemedicine and DNA testing companies like Maven and Natera[1][2][3].